vs
Calumet, Inc.（CLMT）与礼蓝动物保健（ELAN）财务数据对比。点击上方公司名可切换其他公司
礼蓝动物保健的季度营收约是Calumet, Inc.的1.1倍（$1.1B vs $1.0B），Calumet, Inc.净利率更高（-3.6% vs -24.1%，领先20.5%），Calumet, Inc.自由现金流更多（$103.8M vs $46.0M）
Calumet是总部位于美国的特种产品企业，专注于生产和分销高价值碳氢化合物与特种化学品，产品覆盖特种油、润滑剂、蜡制品及可再生燃料解决方案，服务北美及全球的工业、消费、交通等下游领域。
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
CLMT vs ELAN — 直观对比
营收规模更大
ELAN
是对方的1.1倍
$1.0B
净利率更高
CLMT
高出20.5%
-24.1%
自由现金流更多
CLMT
多$57.8M
$46.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.1B |
| 净利润 | $-37.3M | $-276.0M |
| 毛利率 | -0.3% | 51.5% |
| 营业利润率 | -6.2% | -22.6% |
| 净利率 | -3.6% | -24.1% |
| 营收同比 | — | 12.2% |
| 净利润同比 | — | -3350.0% |
| 每股收益（稀释后） | $-0.43 | $-0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLMTELAN
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $993.9M | $1.2B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润CLMTELAN
| Q4 25 | $-37.3M | $-276.0M | ||
| Q3 25 | $313.4M | $-34.0M | ||
| Q2 25 | $-147.9M | $11.0M | ||
| Q1 25 | $-162.0M | $67.0M | ||
| Q4 24 | — | $-8.0M | ||
| Q3 24 | $-100.6M | $364.0M | ||
| Q2 24 | $-39.1M | $-50.0M | ||
| Q1 24 | — | $32.0M |
毛利率CLMTELAN
| Q4 25 | -0.3% | 51.5% | ||
| Q3 25 | 34.7% | 53.4% | ||
| Q2 25 | -4.2% | 57.5% | ||
| Q1 25 | -8.2% | 57.3% | ||
| Q4 24 | — | 50.9% | ||
| Q3 24 | 0.4% | 52.2% | ||
| Q2 24 | 5.6% | 58.2% | ||
| Q1 24 | — | 57.3% |
营业利润率CLMTELAN
| Q4 25 | -6.2% | -22.6% | ||
| Q3 25 | 30.0% | -4.4% | ||
| Q2 25 | -9.8% | 2.0% | ||
| Q1 25 | -4.9% | 5.0% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | -5.2% | 54.3% | ||
| Q2 24 | 0.5% | -2.7% | ||
| Q1 24 | — | 1.0% |
净利率CLMTELAN
| Q4 25 | -3.6% | -24.1% | ||
| Q3 25 | 29.1% | -3.0% | ||
| Q2 25 | -14.4% | 0.9% | ||
| Q1 25 | -16.3% | 5.6% | ||
| Q4 24 | — | -0.8% | ||
| Q3 24 | -9.1% | 35.3% | ||
| Q2 24 | -3.4% | -4.2% | ||
| Q1 24 | — | 2.7% |
每股收益（稀释后）CLMTELAN
| Q4 25 | $-0.43 | $-0.55 | ||
| Q3 25 | $3.61 | $-0.07 | ||
| Q2 25 | $-1.70 | $0.02 | ||
| Q1 25 | $-1.87 | $0.13 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-1.18 | $0.73 | ||
| Q2 24 | $-0.48 | $-0.10 | ||
| Q1 24 | — | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.1M | $545.0M |
| 总债务越低越好 | $2.1B | $3.9B |
| 股东权益账面价值 | $-732.7M | $6.5B |
| 总资产 | $2.7B | $13.4B |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资CLMTELAN
| Q4 25 | $125.1M | $545.0M | ||
| Q3 25 | $94.6M | $505.0M | ||
| Q2 25 | $110.6M | $539.0M | ||
| Q1 25 | $123.4M | $487.0M | ||
| Q4 24 | — | $468.0M | ||
| Q3 24 | $34.6M | $490.0M | ||
| Q2 24 | $7.0M | $416.0M | ||
| Q1 24 | — | $345.0M |
总债务CLMTELAN
| Q4 25 | $2.1B | $3.9B | ||
| Q3 25 | $2.1B | $4.0B | ||
| Q2 25 | $2.1B | $4.1B | ||
| Q1 25 | $2.3B | $4.4B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | $1.7B | $4.4B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $5.8B |
股东权益CLMTELAN
| Q4 25 | $-732.7M | $6.5B | ||
| Q3 25 | $-695.3M | $6.7B | ||
| Q2 25 | $-1.0B | $6.8B | ||
| Q1 25 | $-862.3M | $6.4B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | $-672.2M | $6.5B | ||
| Q2 24 | $-566.4M | $5.9B | ||
| Q1 24 | — | $6.1B |
总资产CLMTELAN
| Q4 25 | $2.7B | $13.4B | ||
| Q3 25 | $2.7B | $13.6B | ||
| Q2 25 | $2.8B | $13.7B | ||
| Q1 25 | $2.8B | $12.9B | ||
| Q4 24 | — | $12.6B | ||
| Q3 24 | $2.6B | $13.3B | ||
| Q2 24 | $100 | $13.8B | ||
| Q1 24 | — | $14.0B |
负债/权益比CLMTELAN
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.70× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | — | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $116.5M | $108.0M |
| 自由现金流经营现金流 - 资本支出 | $103.8M | $46.0M |
| 自由现金流率自由现金流/营收 | 10.0% | 4.0% |
| 资本支出强度资本支出/营收 | 1.2% | 5.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $56.6M | $284.0M |
8季度趋势，按日历期对齐
经营现金流CLMTELAN
| Q4 25 | $116.5M | $108.0M | ||
| Q3 25 | $23.5M | $219.0M | ||
| Q2 25 | $-1.8M | $237.0M | ||
| Q1 25 | $-29.3M | $-4.0M | ||
| Q4 24 | — | $177.0M | ||
| Q3 24 | $-15.5M | $162.0M | ||
| Q2 24 | — | $200.0M | ||
| Q1 24 | — | $2.0M |
自由现金流CLMTELAN
| Q4 25 | $103.8M | $46.0M | ||
| Q3 25 | $15.1M | $127.0M | ||
| Q2 25 | $-15.4M | $180.0M | ||
| Q1 25 | $-46.9M | $-69.0M | ||
| Q4 24 | — | $130.0M | ||
| Q3 24 | $-32.2M | $120.0M | ||
| Q2 24 | — | $166.0M | ||
| Q1 24 | — | $-22.0M |
自由现金流率CLMTELAN
| Q4 25 | 10.0% | 4.0% | ||
| Q3 25 | 1.4% | 11.2% | ||
| Q2 25 | -1.5% | 14.5% | ||
| Q1 25 | -4.7% | -5.8% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | -2.9% | 11.7% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | — | -1.8% |
资本支出强度CLMTELAN
| Q4 25 | 1.2% | 5.4% | ||
| Q3 25 | 0.8% | 8.1% | ||
| Q2 25 | 1.3% | 4.6% | ||
| Q1 25 | 1.8% | 5.4% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | 1.5% | 4.1% | ||
| Q2 24 | 2.2% | 2.9% | ||
| Q1 24 | — | 2.0% |
现金转化率CLMTELAN
| Q4 25 | — | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | — | 21.55× | ||
| Q1 25 | — | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLMT
| Specialty Products And Solutions | $675.9M | 65% |
| Montana Renewables | $294.2M | 28% |
| Performance Brands | $68.5M | 7% |
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
